European
Dementia & Alzheimer's Disease Conference

 Theme  :  Progressions and Innovations in the Fields of Dementia and Alzheimer’s Research

  June 29-30, 2020

 Rome, Italy

 Conference Brochure  Abstract Submission  Organizing Committee  Conference Program

Dementia 2020

On behalf of the Coalesce Research Group, it gives us immense pleasure to invite you to the “European Dementia & Alzheimer's Disease Conference” that is scheduled to be held on June 29-30, 2020 at Rome, Italy.

This program is designed to update practitioners who care for patients with Alzheimer’s disease and dementia with an in-depth knowledge of recent, cutting-edge advancements in Dementia and Alzheimer’s in order to stimulate knowledge and information among medical practitioners and to create a platform for communication between leading experts and professionals in the field of Dementia and Alzheimer’s.

The main theme of the conference is “Progressions and Innovations in the Fields of Dementia and Alzheimer’s Research” the conference includes thought provoking keynote lectures, updates of multiple topics, plenary sessions, oral presentations, poster presentations and expert review and discussion on the hottest topics in Dementia, Alzheimer’s  and related diseases. The two days event will bring together the foremost thought leaders and experts in Dementia & Alzheimer’s disease and related specialties from all over the world to present data on multiple topics.

We look forward, to a memorable Dementia Conference

See you in Rome on June 29-30, 2020.

Dementia 2020 Sessions:

Session 1: Managing Dementia

Dementia is a syndrome, usually of a chronic or progressive nature in which there is deterioration in cognitive function (i.e. the ability to process thought) beyond what might be expected from normal ageing. It affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement. Consciousness is not affected. The impairment in cognitive function is commonly accompanied, and occasionally preceded, by deterioration in emotional control, social behavior, or motivation. Dementia results from a variety of diseases and injuries that primarily or secondarily affect the brain, such as Alzheimer's disease or stroke.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 2: Care Practice and Awareness

Engagement in meaningful activities is one of the critical elements of good dementia care underscoring that such opportunities can not only help residents preserve their functional abilities but enhance their overall quality of life. Dementia Care Practice Recommendations were developed to better define quality care across all care settings, and throughout the disease course. They are intended for professional care providers who work with individuals living with dementia and their families in residential and community-based care settings.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 3: Alzheimer’s Disease Imaging

The current diagnosis of Alzheimers disease is made by clinical, neuropsychological, and neuroimaging assessments. Routine structural neuroimaging evaluation has long been based on nonspecific features such as atrophy, which is a late feature in the progression of the disease. More recently, a variety of imaging modalities, including structural and functional magnetic resonance imaging (MRI) and positron emission tomography (PET) studies of cerebral metabolism, have shown characteristic changes in the brains of patients with Alzheimer disease in prodromal and even presymptomatic states.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 4: Behavioral problems in Alzheimer’s Disease

Alzheimer’s disease causes brain cells to die, so the brain works less well over time. This changes how a person acts. The common behaviors include Angry Outbursts and Physical Aggression, Hand-wringing, Pacing and Rocking, Accusing Loved Ones of Wrongdoing and Hallucinating, Repeating Stories and Leaving the House Unassisted, Sleep Problems and Sundowning.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 5: Alzheimer’s Disease Diagnosis and Symptoms

To diagnose Alzheimer's dementia, doctors conduct tests to assess memory impairment and other thinking skills, judge functional abilities, and identify behavior changes. They also perform a series of tests to rule out other possible causes of impairment.

  • Early signs and symptoms of Alzheimer's dementia include:
  • Memory impairment, such as difficulty remembering events
  • Difficulty concentrating, planning or problem-solving
  • Problems finishing daily tasks at home or at work
  • Confusion with location or passage of time
  • Having visual or space difficulties, such as not understanding distance in driving, getting lost or misplacing items
  • Language problems, such as word-finding problems or reduced vocabulary in speech or writing
  • Using poor judgment in decisions
  • Withdrawal from work events or social engagements
  • Changes in mood, such as depression or other behavior and personality changes

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 6: Causes and Prevention of Alzheimer’s

In Alzheimer’s disease, brain cells start to deteriorate. The body attempts to stop this process by producing a protein called amyloid. However, amyloid deposits build up in the brain, leading to further deterioration. These deposits of amyloid are referred to as "plaques" and cause the brain cells to shrivel up and form "tangles", which in turn lead to changes in the brain structure and cause the brain cells to die. The formation of plaques and tangles also prevents the production of some important brain chemicals, called neurotransmitters. Over time the loss of brain cells causes the brain to shrink.

While there is no known cause for Alzheimer's disease, some research studies have indicated that the following factors may play an important role in the development of the condition: Genetic factors, Environmental factors, Lifestyle factors.

There are no proven ways to prevent the development of Alzheimer's disease.  However, there is epidemiological evidence to suggest that leading a healthy lifestyle can reduce the risk of Alzheimer's disease.  Regular physical activity and exercise may have a general protective effect on brain health and may slow progression of Alzheimer's disease.  Although there are no specific dietary specifications for Alzheimer's, a Mediterranean-style diet (ie: plant foods such as vegetables, fruits, beans, whole grains, nuts, olives and olive oil, along with some cheeses, yoghurt, fish, poultry and eggs) may reduce the risk of Alzheimer's disease, and has the added benefit of lowering cardiovascular disease and type 2 diabetes risk. 

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 7: Alzheimer’s Disease Pathophysiology and Disease Mechanisms

Alzheimer disease (AD) is a neurodegenerative disorder marked by cognitive and behavioral impairment that significantly interferes with social and occupational functioning. It is an incurable disease with a long preclinical period and progressive course. In AD, plaques develop in the hippocampus, a structure deep in the brain that helps to encode memories, and in other areas of the cerebral cortex that are involved in thinking and making decisions. Whether plaques themselves cause AD or whether they are a by-product of the AD process remains unknown. The following image depicts one of the cardinal neuroimaging findings in AD – hippocampal atrophy.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 8: Neurodegenerative Diseases

Neurodegenerative diseases occur when nerve cells in the brain or peripheral nervous system lose function over time and ultimately die. Although treatments may help relieve some of the physical or mental symptoms associated with neurodegenerative diseases, there is currently no way to slow disease progression and no known cures. The risk of being affected by a neurodegenerative disease increases dramatically with age. Population-wide health improvements have increased lifespan which, along with a larger generation of aging Americans, means more people may be affected by neurodegenerative diseases in coming decades. This creates a critical need to improve our understanding of what causes neurodegenerative diseases and develop new approaches for treatment and prevention.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 9: Vascular Dementia           

Vascular dementia is a common type of dementia caused by reduced blood flow to the brain. Vascular dementia, also known as multi-infarct dementia is the second most common cause of dementia in older people. Because it has a lower profile than Alzheimer's, many people don't suspect vascular dementia when forgetfulness becomes problematic. It's also difficult to diagnose so it's difficult to know exactly how many people suffer from vascular dementia. Some symptoms may be similar to those of other types of dementia. Memory loss is common in the early stages of Alzheimer's, but is not usually the main early symptom of vascular dementia.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 10: Alzheimer’s Clinical Trials and Studies

Without clinical trials, there can be no better treatments, no prevention and no cure for Alzheimer's disease. Clinical trials area unit inquired concerning examinations semiconductor diode in people to determine if medicines area unit protected and viable. while not clinical analysis and therefore the help of human volunteers, there is no higher medications, no compensatory action and no cure for Alzheimer’s complaint. Clinical trials area unit sometimes alluded to as clinical examinations; the terms area unit oftentimes utilized reciprocally, nonetheless their area unit unnoticeable contrasts between them. Clinical trials look at new intercessions or medications to avoid, acknowledge or treat infection. A clinical report is any variety of clinical analysis as well as people, paying very little heed as to whether it's Associate in Nursing an intercession. Clinical examinations will likewise take a goose at completely different components of care, for instance, enhancing personal satisfaction.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 11: Therapeutic Targets and Mechanisms for Treatment

Alzheimer's disease (AD) is one of the most common multifactorial diseases, including a range of abnormal cellular/molecular processes occurring in different regions of the brain. This disease is considered to be a major contributor to dementia in the elderly people. The pathophysiology involves accumulation of extracellular plaques containing the ?-amyloid protein which is generated by the breakdown of the ?-amyloid precursor protein (APP) in the brain. Another mechanism involves formation of intracellular neurofibrillary tangles of hyperphosphorylated tau protein. The AD can be classified into two types, familial AD (FAD) and sporadic AD (SAD) based on heritability apart from this the early-onset AD (EOAD) and late-onset AD (LOAD) forms are based on the age of onset. Some proteins, such as APOE, APP, BACE (b-amyloid cleaving enzyme), secretases, PS1/2 and tau proteins are reported in AD brain and have been correlated with disease. It is still unclear whether this disease comprises genetic or environmental factors or both. Many palliative drugs are available for the disease but there is still thirst for curative drugs with greater efficacy. It is required to understand the key factors involved in disease progression and their suitability as drug targets for discovering new drugs against Alzheimer's disease.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 12: Animal Models and Translational Medicine

Animal models for Alzheimer’s sickness it's necessary to have faith in the human composition and what's being shapely in terms of the animal composition. The moderator, Bradley Hyman, academic of neurology at Harvard grad school, same that animal models of Alzheimer’s sickness, supported the biology of the sickness and therefore the closely connected frontotemporal dementedness, replicate a minimum of several the pathology. Researchers are undefeated at modeling terribly specific aspects of Alzheimer’s sickness within the mouse (e.g., plaques, tangles). though these are incomplete models of the human sickness, they need been well received within the field as doubtless relevant models to be used in drug discovery.

Patients with Alzheimer’s sickness can show each amyloidopathy and tauopathy, but scientists typically focus, in an exceedingly theory manner, on one or the opposite in associate degree animal model. A participant additional that although the anatomy within the mouse is completely different than the human, mutant alphabetic character mice are comparatively smart models in this they recapitulate tau-dependent neurodegeneration. This has diode several corporations to specialize in antibodies that block tau-dependent neurodegeneration in these mouse models.

This session includes Transgenic models, pharmacologic and lesion models, Natural and semi natural models, Primate models, equine fish models, Animal models of human psychological feature aging, Development of latest animal models, biology of travel models, Protein-protein interactions, moral problems with animal models.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 13: Nursing care in Dementia

The danger of creating dementia increments with age, as does the danger of growing long-haul conditions, for example, joint inflammation, diabetes, and cerebrovascular or respiratory issues. 'Seniority' happens prior to individuals with learning incapacities, and this gathering is especially defenseless against intellectual impedance. Individuals with dementia in this manner regularly have coinciding issues or comorbidities. Whenever 25% of patients in a general doctor's facility may have dementia and this gathering is at higher danger of readmission and passing than different patients conceded with similar conditions – this implies the distinguishing proof and care of individuals with dementia is an urgent obligation regarding medical caretakers.

• Encouraging exercise

• Encouraging socialization

• Encouraging mental incitement

• Encouraging important action and subjective incitement

• Encouraging individuals with dementia to look after freedom

• Providing support for families and careers

• Stigmatization

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences
34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

Session 14: Recent Studies & Case Reports

Dementia may be a progressive, irreversible decline in knowledge that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has many etiologies of that Alzheimer’s unwellness (AD) is that the commonest.

Drug development in AD relies on evolving pathophysiological theory. Unwellness modifying approaches embody the targeting of amyloid process, aggregation of alphabetic character, internal secretion communication, neuro-inflammation and neurochemical pathology, with efforts to this point yielding abandoned hopes and current promise. reflective its dominance on the pathophysiological stage the amyloid cascade is central to several of the rising drug therapies.

Major Conferences: Dementia Conferences | Alzheimer’s Conferences | Dementia Conferences 2020 | Dementia Conferences 2020 Europe | Dementia Conferences America | Dementia Conferences Asia | European Dementia Conferences

34th International Conference of ADI "Hope in the age of dementia” during March 19-21, 2020 at Singapore; 14th World Congress on Controversies in Neurology during March 26-29, 2020 at London, UK; Alzheimer’s Association International Conference (AAIC) during July 26-30, 2020 at Amsterdam, Netherlands.

 

 

For Speakers: 

  • Keep the number of slides in your Presentation to a minimum and follow the assigned slots.
  • Please stop when signaled to do so by the Chair.
  • Personal laptops should not be used unless in any unavoidable conditions.
  • The Videos will not be recorded.
  • Question Sessions, thanks and acknowledgement of the speakers will take place during the session or after completion of the session, so please stay until the end of the session.

For Poster

  • Each poster should be approximately 1x1 M in Size The title, contents, text and the author’s information should be clearly visible even from 1-2 feet.
  • Present numerical data in the form of graphs, rather than tables.
  • If data must be presented in table-form, keep it Simple to be easily understandable.
  • Visuals should be simple, clear and bold. Avoid acronyms and mathematical notations as much as possible.
  • Posters with 800-1000 words or less are perfect.
  • Avoid submitting compactly packed, highly worded- count posters.
  • Categorize your poster into subdivisions, e.g., Introduction, Methods, Results; Discussion, Conclusions, and Literature Cited.
  • Use bright colors to enhance the better visibility Besides your project, you can also include future research plans or questions.

Opportunities for Conference Attendees:

For Researchers & Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Presentation Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (Award to the best presenter)
  • Student Attendee
  • Group Registrations

For Business Speakers:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

Abstract Peer-review Process/Guidelines:

  • The Reviewing Committee of Dementia Conferences ensures high-quality peer review process for all abstracts submitted to the conference.
  • The decision of abstract acceptance will be judged by a panel of experts emphasizing whether the findings and / or conclusions are novel and make useful contributions to the field.
  • The committee operates a single / double-blind peer review process for all the abstracts submitted, where both the reviewer and the author remain anonymous.

The following are the steps that each abstract of Dementia Conferences undergoes during the process of peer review:

  • All submitted abstracts are reviewed by internal editorial team to ensure adherence to the conference scope and abstracts which have passed this initial screening are then assigned to the session chair / review committee for evaluation.
  • Once the reviews have been received, the review committee decides to accept or reject a manuscript, or to request revisions from the author in response to the reviewers’ comments. If the decision tends to be minor revision or major revision, authors will be given 14 days to resubmit the revised abstract.

Criteria to be considered for Scoring:
The abstract should be reviewed according to the following criteria:

  • Originality of concept/approach and level of innovativeness
  • Significance/impact/relevance to conference theme
  • Quality of research design/theoretical argument
  • Conclusions and interpretations of results
  • Presentation style: Coherence and clarity of structure

Top Reasons to attend Dementia 2020

  • Presenting a paper

Presenting a paper is one of the main objectives of a conference participant. The presenter will have the chance to present a paper in front of colleagues of the same or similar fields of study and will be able to receive positive feedback and constructive criticism about their research. The exchange of ideas on fields of interests seeds the links for future collaborations across the world.

  • Networking for future collaborations

Attending a conference is an opportunity to build networks with other academics, business and experts in the same or similar field of studies all around the world and to share thoughts on recent advances and technological breakthroughs. It is an opportunity to expand the knowledge that one has and upgrade performance in accomplishing institutional objectives. Conferences bring together people who share a common discipline from different parts of the world, bringing different forms of ideas which build into something greater. As you step up and attend this conference you build a network of people who can raise your caliber of work to greater heights as you achieve shared objectives.

  • Publication

Another common reason for attending a conference is no doubt publication. Conference proceedings are always a good way to have your research published and indexed. You’ll also could publish your research.

  • Socialization and the culture factor

Meeting new people with different cultures and dispositions enlightens your way of thinking in your field of study. You will witness some of the many different aspects and solutions which exist on the same issues. You’ll also have the chance to socialize with your colleagues at coffee breaks, lunches and other activities. Imagine a conference without socializing or learning more about other people’s cultural tradition? This cannot be summed up adequately as people from different parts of the world who have uniqueness in their ways of living which you are often surprised to learn from.

  • Travelling

An academic conference is a great way to have a “break” from your academic responsibilities at the university, hospital or company and discover different cities of the world. Be assured that you’ll feel relaxed and refreshed when you return to your institution/hospital after the conference.

  • Find out what’s new

It is vital to find out what’s new in your field of study to survive in an academic or business discipline. These conferences will keep you updated on new findings that have taken place. This is in fact one of the major reasons why one should attend an academic conference.

  • The focus and energy of Like-Minded Individuals

When one attends an academic conference, he or she is sure to meet people of his or her same stature, mindset and goals. This is a motivational factor as one aspires to overcome fears and achieve one’s dreams.

  • Added Research Value

For students and researchers, academic conferences help to make research on a subject easier. They provide access to various research activities related to a subject with current findings and developments anticipated from them.

  • Conclusion

In today’s fast changing world, attending a conference has become a “must” to survive in an academic discipline. Many academics have become aware of this fact as the number of conferences and participants increase dramatically. We look forward to collaborating with you at a Dementia 2020 conference!

WHO SHOULD ATTEND

This activity is designed to meet the educational needs of practicing physicians and other healthcare professionals interested in learning the latest information on diseases specific to Dementia and Alzheimer’s, including:

Neurologists
Neuroscientists
Neurosurgeons
Physicians
Healthcare professionals
Neuro drug Manufacturers
Psychiatrists
General Practitioners
Neuro Physiotherapists
Medical and Surgical
Nurses
Pharmacists
Nurses
Medical Students
And Allied Healthcare professionals interested in the topic

 Twitter
 Facebook

Know Your Registration

Speaker Registration
€ 589

  • Access to all Conference Sessions
  • Opportunity to give a Keynote/ Plenary/ Poster Presentations/ Workshop
  • Opportunity to publish your Abstract in any of our esteemed Journals & in the Conference Proceedings Book
  • Certificate Accredited by our Organizing Committee Member
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference

Delegate Registration
€ 545

  • Access to all Conference Sessions
  • Can meet the Experts of your Area of expertise arriving from 22+ different Countries
  • Participation Certificate Accredited by our Organizing Committee Member
  • Delegates are not allowed to present their papers in Oral or Poster sessions
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference

Student Registration
€ 409

  • Access to all Conference Sessions
  • Opportunity to give an Oral/ Poster Presentation
  • Opportunity to publish your Abstract in any of our esteemed Journals & in the Conference Proceedings Book
  • Certificate Accredited by our Organizing Committee Member
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference

+1-315-902-2237